Literature DB >> 19687004

Urgent angioembolization with early elective nephron-sparing surgery for spontaneously ruptured renal angiomyolipoma.

Yeong-Chin Jou1, Wen-Pin Chen, Chun-Lin Huang.   

Abstract

Tumor rupture with hemorrhage is a severe complication of renal angiomyolipoma. Urgent transcatheter arterial embolization is an effective method for the patient suffering from life-threatening hemorrhage due to ruptured angiomyolipoma. Elective surgery has been suggested because of the possibility of rebleeding or abscess formation after embolization. However, it is not easy to perform a nephron-sparing procedure by delayed elective surgery due to severe tissue adhesion after bleeding. Herein, we report 2 cases of ruptured renal angiomyolipoma initially managed with transcatheter arterial embolization. Nephron-sparing surgery was performed a few days after embolization, before tissue adhesion occurred. Both kidneys were preserved, and the postoperative course was uneventful.

Entities:  

Mesh:

Year:  2009        PMID: 19687004     DOI: 10.1016/S1726-4901(09)70405-8

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  4 in total

1.  A Case Series & Review of Literature of Angiomyolipoma with Medical & Surgical Perspective.

Authors:  Santosh Kumar; Kumar Jayant; Shrawan Kumar Singh; Swati Agrawal
Journal:  J Clin Diagn Res       Date:  2015-09-01

2.  Urgent arterial embolization of ruptured renal angiomyolipoma.

Authors:  Selim Kervancioglu; Feyza Yilmaz
Journal:  Open Med (Wars)       Date:  2015-04-02

Review 3.  The Risks of Renal Angiomyolipoma: Reviewing the Evidence.

Authors:  Raouf M Seyam; Waleed K Alkhudair; Said A Kattan; Mohamed F Alotaibi; Hassan M Alzahrani; Waleed M Altaweel
Journal:  J Kidney Cancer VHL       Date:  2017-10-16

Review 4.  Endovascular Interventional Radiology of the Urogenital Tract.

Authors:  Fabio Pozzi Mucelli; Roberta A Pozzi Mucelli; Cristina Marrocchio; Saverio Tollot; Maria A Cova
Journal:  Medicina (Kaunas)       Date:  2021-03-17       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.